Can we select individuals with low risk ductal carcinoma in situ (DCIS)? A population-based outcomes analysis

Breast Cancer Research and Treatment

Volumn 138, Issue 2, 2013, Pages 581-590

  Rakovitch, Eileen ^a,b   Nofech Mozes, Sharon ^a,b   Narod, Steven A ^a,b   Hanna, Wedad ^a,b   Thiruchelvam, Deva ^a   Saskin, Refik ^a   Taylor, Carole ^a   Tuck, Alan ^g   Sengupta, Sandip ^c   Elavathil, Leela ^d   Jani, Prashant A ^e   Done, Susan J ^b,f   Miller, Naomi ^b,f   Youngson, Bruce ^b,f   Kong, Iwa ^a,b   Paszat, Lawrence ^a,b  

^a SUNNYBROOK RESEARCH INSTITUTE   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c KINGSTON GENERAL HOSPITAL   (Canada)

^d HENDERSON GENERAL HOSPITAL   (Canada)

^e THUNDER BAY REGIONAL HEALTH SCIENCES CENTRE   (Canada)

^f PRINCESS MARGARET HOSPITAL   (Canada)

^g LONDON HEALTH SCIENCES CENTRE   (Canada)

Author keywords

Ductal carcinoma in situ; Population based; Radiotherapy; Recurrence

Indexed keywords

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; CANCER RADIOTHERAPY; CANCER RISK; CANCER SURVIVAL; CLINICAL EVALUATION; FEMALE; FOLLOW UP; HUMAN; INTRADUCTAL CARCINOMA; LOCAL RECURRENCE FREE SURVIVAL; MAJOR CLINICAL STUDY; OUTCOME ASSESSMENT; PARTIAL MASTECTOMY; POPULATION RISK; PRIORITY JOURNAL; RISK ASSESSMENT; SURVIVAL RATE; SURVIVAL TIME;

ADULT; AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; CARCINOMA, INTRADUCTAL, NONINFILTRATING; COHORT STUDIES; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; INCIDENCE; MASTECTOMY, SEGMENTAL; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; ONTARIO; POPULATION; RISK; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84879413438     PISSN: 01676806     EISSN: 15737217     Source Type: Journal    
DOI: 10.1007/s10549-013-2455-8     Document Type: Article

References (32)

1. Ernster VL, Ballard-Barbash R, Barlow WE, Zheng Y, Weaver DL, Cutter G, Yankaskas BC, Rosenberg R, Carney PA, Kerlikowske K et al (2002) Detection of ductal carcinoma in situ in women undergoing screening mammography. J Natl Cancer Inst 94(20):1546-1554 (Pubitemid 35277278)
2. Correa C, McGale P, Taylor C, Wang Y, Clarke M, Davies C, Peto R, Bijker N, Solin L, Darby S (2010) Overview of the randomized trials of radiotherapy in ductal carcinoma in situ of the breast. J Natl Cancer Inst Monogr 2010(41):162-177
3. Wapnir IL, Dignam JJ, Fisher B, Mamounas EP, Anderson SJ, Julian TB, Land SR, Margolese RG, Swain SM, Costantino JP et al (2011) Long-term outcomes of invasive ipsilateral breast tumor recurrences after lumpectomy in NSABP B-17 and B-24 randomized clinical trials for DCIS. J Natl Cancer Inst 103(6):478-488
4. Fisher B, Dignam J, Wolmark N, Mamounas E, Costantino J, Poller W, Fisher ER, Wickerham DL, Deutsch M, Margolese R et al (1998) Lumpectomy and radiation therapy for the treatment of intraductal breast cancer: findings from National Surgical Adjuvant Breast and Bowel Project B-17. J Clin Oncol 16(2):441-452 (Pubitemid 28135585)
5. Holmberg L, Garmo H, Granstrand B, Ringberg A, Arnesson LG, Sandelin K, Karlsson P, Anderson H, Emdin S (2008) Absolute risk reductions for local recurrence after postoperative radiotherapy after sector resection for ductal carcinoma in situ of the breast. J Clin Oncol 26(8):1247-1252
6. Houghton J, George WD, Cuzick J, Duggan C, Fentiman IS, Spittle M (2003) Radiotherapy and tamoxifen in women with completely excised ductal carcinoma in situ of the breast in the UK, Australia, and New Zealand: randomised controlled trial. Lancet 362(9378):95-102 (Pubitemid 36831018)
7. Julien JP, Bijker N, Fentiman IS, Peterse JL, Delledonne V, Rouanet P, Avril A, Sylvester R, Mignolet F, Bartelink H et al (2000) Radiotherapy in breast-conserving treatment for ductal carcinoma in situ: first results of the EORTC randomised phase III trial 10853. EORTC Breast Cancer Cooperative Group and EORTC Radiotherapy Group. Lancet 355(9203):528-533 (Pubitemid 30088672)
8. Cohen AL, Ward JH (2010) Risk reduction strategies for ductal carcinoma in situ. J Natl Compr Cancer Netw 8(10):1211-1217
9. Olivotto I, Levine M (2001) Clinical practice guidelines for the care and treatment of breast cancer: the management of ductal carcinoma in situ (summary of the 2001 update). Can Med Assoc J 165(7):912-913 (Pubitemid 34028232)
10. Schwartz GF, Solin LJ, Olivotto IA, Ernster VL, Pressman P (2000) The consensus conference on the treatment of in situ ductal carcinoma of the breast, 22-25 April 1999. Breast 9(4):177-186
11. Jackson LC, Camacho F, Levine EA, Anderson RT, Stewart JH (2008) Patterns of care analysis among women with ductal carcinoma in situ in North Carolina. Am J Surg 195(2):164-169
12. Baxter NN, Virnig BA, Durham SB, Tuttle TM (2003) Patterns of care for DCIS: consistency with standard recommendations. In: 2003 ASCO annual meeting, vol 22: Proceedings of the American society clinical oncology
13. Baxter NN, Virnig BA, Durham SB, Tuttle TM (2004) Trends in the treatment of ductal carcinoma in situ of the breast. J Natl Cancer Inst 96(6):443-448 (Pubitemid 38443647)
14. Hughes LL, Wang M, Page DL, Gray R, Solin LJ, Davidson NE, Lowen MA, Ingle JN, Recht A, Wood WC (2009) Local excision alone without irradiation for ductal carcinoma in situ of the breast: a trial of the Eastern Cooperative Oncology Group. J Clin Oncol 27(32):5319-5324
15. Silverstein MJ, Lagios MD, Groshen S, Waisman JR, Lewinsky BS, Martino S, Gamagami P, Colburn WJ (1999) The influence of margin width on local control of ductal carcinoma in situ of the breast. N Engl J Med 340(19):1455-1461 (Pubitemid 29220544)
16. Wong JS, Kaelin CM, Troyan SL, Gadd MA, Gelman R, Lester SC, Schnitt SJ, Sgroi DC, Silver BJ, Harris JR et al (2006) Prospective study of wide excision alone for ductal carcinoma in situ of the breast. J Clin Oncol 24(7):1031-1036 (Pubitemid 46638798)
17. McCormick B (2012) RTOG 9804: a prospective randomized trial for "good risk" ductal carcinoma in situ (DCIS), comparing radiation (RT) to observation (OBS). In: 2012 ASCO annual meeting, vol 30: Journal of Clinical Oncology
18. Kerlikowske K, Molinaro A, Cha I, Ljung BM, Ernster VL, Stewart K, Chew K, Moore DH 2nd, Waldman F (2003) Characteristics associated with recurrence among women with ductal carcinoma in situ treated by lumpectomy. J Natl Cancer Inst 95(22):1692-1702 (Pubitemid 37509078)
19. Wai ES, Lesperance ML, Alexander CS, Truong PT, Moccia P, Culp M, Lindquist J, Olivotto IA (2011) Predictors of local recurrence in a population-based cohort of women with ductal carcinoma in situ treated with breast conserving surgery alone. Ann Surg Oncol 18(1):119-124
20. Currie AM, Fricke T, Gawne A, Johnston R, Liu J, Stein B (2006) Automated extraction of free-text from pathology reports. AMIA Annu Symp Proc 2006:899
21. Rakovitch E, Pignol JP, Chartier C, Hanna W, Kahn H, Wong J, Mai V, Paszat L (2007) The management of ductal carcinoma in situ of the breast: a screened population-based analysis. Breast Cancer Res Treat 101(3):335-347 (Pubitemid 46169888)
22. Deyo RA, Cherkin DC, Ciol MA (1992) Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. J Clin Epidemiol 45(6):613-619
23. Morrow M, Strom EA, Bassett LW, Dershaw DD, Fowble B, Harris JR, O'Malley F, Schnitt SJ, Singletary SE, Winchester DP (2002) Standard for the management of ductal carcinoma in situ of the breast (DCIS). CA Cancer J Clin 52(5):256-276 (Pubitemid 35345498)
24. Moran MS, Bai HX, Harris EE, Arthur DW, Bailey L, Bellon JR, Carey L, Goyal S, Halyard MY, Horst KC et al (2012) ACR appropriateness criteria(®) ductal carcinoma in situ. Breast J 18(1):8-15
25. Maass N, Alkasi O, Bauer M, Jonat W, Souchon R, Meinhold-Heerlein I (2009) Actual management of ductal carcinoma in situ of the breast. Arch Gynecol Obstet 280(5):699-705
26. Cutuli B, Fourquet A, Luporsi E, Arnould L, Caron Y, Cremoux P, Dilhuydy JM, Fondrinier E, Fourme E, Giard-Lefevre S et al (2005) Standards, options and recommendations for the management of ductal carcinoma in situ of the breast (DCIS): update 2004. Bull Cancer 92(2):155-168 (Pubitemid 40396123)
27. Warren JL, Weaver DL, Bocklage T, Key CR, Platz CE, Cronin KA, Ballard-Barbash R, Willey SC, Harlan LC (2005) The frequency of ipsilateral second tumors after breast-conserving surgery for DCIS: a population based analysis. Cancer 104(9):1840-1848 (Pubitemid 41513166)
28. Joslyn SA (2006) Ductal carcinoma in situ: trends in geographic, temporal, and demographic patterns of care and survival. Breast J 12(1):20-27 (Pubitemid 43381446)
29. Rakovitch E, Mihai A, Pignol JP, Hanna W, Kwinter J, Chartier C, Ackerman I, Kim J, Pritchard K, Paszat L (2004) Is expert breast pathology assessment necessary for the management of ductal carcinoma in situ? Breast Cancer Res Treat 87(3):265-272 (Pubitemid 39505943)
30. Staradub VL, Messenger KA, Hao N, Wiley EL, Morrow M (2002) Changes in breast cancer therapy because of pathology second opinions. Ann Surg Oncol 9(10):982-987 (Pubitemid 35424632)
31. Bijker N, Peterse JL, Duchateau L, Julien JP, Fentiman IS, Duval C, Di Palma S, Simony-Lafontaine J, de Mascarel I, van de Vijver MJ (2001) Risk factors for recurrence and metastasis after breast-conserving therapy for ductal carcinoma-in situ: analysis of European Organization for Research and Treatment of Cancer Trial 10853. J Clin Oncol 19(8):2263-2271 (Pubitemid 32366979)
32. Acadamies IoMotN (2011) Breast cancer and the environment: a life course approach. The National Academies Press, Washington, DC